T-Cell Therapy Market, By Therapy Type (CAR T-cell Therapy, T Cell Receptor (TCR)-based, Tumor Infiltrating Lymphocytes (TIL)-based), By Indication (Hematologic Malignancies, Solid Tumors, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
T-Cell Therapy Market size was valued at USD 2,708.6 Million in 2022, expanding at a CAGR of 34.9% from 2023 to 2030.
T-cell therapy represents a cutting-edge form of immunotherapy focused on the application of T-cells, a type of white blood cell, to address specific medical conditions, with cancer being a prominent target. Within this domain, there exist two primary approaches: T-cell transfer therapy, characterized by tumor-infiltrating lymphocytes (TIL) therapy, and CAR T-cell therapy. Initially explored as a treatment option for metastatic melanoma, T-cell transfer therapy garnered attention due to the robust immune responses elicited by melanomas and their high TIL count. Encouragingly, TIL therapy demonstrated success in certain melanoma cases and showcased promise in the treatment of other cancers, such as cervical squamous cell carcinoma and cholangiocarcinoma.
T-Cell Therapy Market- Market Dynamics
- The rising focus on Developing new therapies for the treatment of diseases is expected to drive the growth of the T-cell therapy market.
The escalating global prevalence of various diseases, with cancer at the forefront, underscores the pressing need for more efficacious and personalized treatment approaches. For instance, according to projections from the National Cancer Institute, a substantial 2.0 million people in the United States alone will receive a cancer diagnosis in 2023. Among these cases, breast cancer stands out, with an estimated 297,790 women and 2,800 men confronting this as the most frequently diagnosed form of cancer. In response to the challenges posed by resistant or recurrent diseases, T-cell therapies are emerging as a promising and tailored treatment option. Recognizing their potential, substantial investments have been funneled into research and development efforts. Moreover, the advancement of innovative biotherapies and the augmentation of biologics\' production and safety standards are anticipated to offer fertile ground for growth in the T-cell therapy sector.
T-Cell Therapy Market- Key Insights
- In line with insights shared by our research analyst, the global T-Cell Therapy market is poised to undergo substantial annual growth at a notable CAGR of approximately 34.9% during the anticipated timeframe spanning from 2023 to 2030.
- The landscape of the T-cell therapy industry is marked by rapid expansion, driven by two key factors: the mounting burden of cancer cases and the heightened focus on extensive research and development endeavors aimed at crafting innovative T-cell therapies.
- When delving into therapy type categorization, it was discerned that CAR T-cell Therapy reigned supreme and secured the largest market share in the year 2022.
- In the realm of indication segmentation, Hematologic Malignancies emerged as the dominant category in 2022.
T-Cell Therapy Market- Segmentation Analysis:
The global T-Cell Therapy Market is structured around key elements, including Therapy Type, Indication, and Region, which facilitate a comprehensive understanding of its dynamics.
In terms of therapy type, the market presents a diverse spectrum, categorized into three distinct segments: CAR T-cell Therapy, Cell Receptor (TCR)-based therapy, and Tumor Infiltrating Lymphocytes (TIL)-based therapy. Of these, it\'s the CAR T-cell Therapy segment that is poised to exert significant influence on market growth. CAR-T therapy represents an innovative approach within T-cell therapy, where T-cells undergo genetic engineering to equip them with a specific receptor, known as CAR (Chimeric Antigen Receptor), enabling precise targeting of cancer cells.
T-Cell Therapy Market- Geographical Insights
Africa. These regions, in turn, are subdivided based on their contributions to the burgeoning business landscape. Projections indicate that North America is positioned to assume a pivotal role in driving market growth. The driving force behind this dominance is the increasing focus of pharmaceutical companies on the development of adoptive therapies. Notably, North America, with the United States at its forefront, stands as a fertile ground for these advancements. This region boasts a thriving ecosystem comprising a multitude of biotech startups, renowned research institutions, and some of the world\'s largest pharmaceutical corporations, all contributing to the remarkable momentum in T-Cell Therapy market growth.
T-Cell Therapy Market- Competitive Landscape:
The realm of T-cell therapy is currently witnessing a surge of innovative players who are reshaping the landscape. These newcomers are diversifying their approaches, with some channeling their efforts into pioneering next-generation CAR-T therapies. Meanwhile, others are venturing into exploring alternative cell types, designing safer treatment methodologies, or devising cost-effective strategies. This era of robust CAR-T therapy development is underscored by the proactive utilization of intellectual property rights by companies, coupled with substantial investments in research and development.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL T-CELL THERAPY MARKET KEY PLAYERS
- Novartis AG
- Merck KGaA
- Gilead Sciences Inc.
- TCR2 Therapeutics Inc
- Bluebird Bio Inc.
- Sorrento Therapeutics
- Fate Therapeutics
- Pfizer Inc.
- Amgen
- Celgene Corporation
GLOBAL T-CELL THERAPY MARKET, BY THERAPY TYPE
- CAR T-cell Therapy
- T Cell Receptor (TCR)-based
- Tumor Infiltrating Lymphocytes (TIL)-based
GLOBAL T-CELL THERAPY MARKET, BY INDICATION
- Hematologic Malignancies
- Solid Tumors
- Others
GLOBAL T-CELL THERAPY MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. T-Cell Therapy Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. T-Cell Therapy Market Snippet by Therapy Type
2.1.2. T-Cell Therapy Market Snippet by Indication
2.1.3. T-Cell Therapy Market Snippet by Country
2.1.4. T-Cell Therapy Market Snippet by Region
2.2. Competitive Insights
3. T-Cell Therapy Key Market Trends
3.1. T-Cell Therapy Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. T-Cell Therapy Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. T-Cell Therapy Market Opportunities
3.4. T-Cell Therapy Market Future Trends
4. T-Cell Therapy Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. T-Cell Therapy Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. T-Cell Therapy Market Landscape
6.1. T-Cell Therapy Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. T-Cell Therapy Market – By Therapy Type
7.1. Overview
7.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
7.1.2. CAR T-cell Therapy
7.1.3. T Cell Receptor (TCR)-based
7.1.4. Tumor Infiltrating Lymphocytes (TIL)-based
8. T-Cell Therapy Market – By Indication
8.1. Overview
8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
8.1.2. Hematologic Malignancies
8.1.3. Solid Tumors
8.1.4. Others
9. T-Cell Therapy Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. T-Cell Therapy Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. T-Cell Therapy Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. T-Cell Therapy Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. T-Cell Therapy Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. T-Cell Therapy Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- T-Cell Therapy Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Novartis AG
10.2.2. Merck KGaA
10.2.3. Gilead Sciences Inc.
10.2.4. TCR2 Therapeutics Inc
10.2.5. Bluebird Bio Inc.
10.2.6. Sorrento Therapeutics
10.2.7. Fate Therapeutics
10.2.8. Pfizer Inc.
10.2.9. Amgen
10.2.10. Celgene Corporation
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
